NEU 3.15% $21.27 neuren pharmaceuticals limited

Share Price, page-3687

  1. 2,202 Posts.
    lightbulb Created with Sketch. 324
    Hi Tony,

    Hottod, has answered your first question, infact ACADIA has spent over one billion USD on R&D since 2019,
    Trofinetides take was AUD $300 million, as Little t, mentioned in a previous post.

    Your 2nd question,
    I don't believe ACADIA is the perfect company for ROW rights, I was suggesting that a company that
    Has spent $300 million on R&D and NDA would want to maximise their investment by bidding for ROW rights.
    Why give away all their hard work to a third party? The BOD will ultimately make the best decision for the SHs.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.